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Method of converting cholesterol in food to coprostanol
Abstract
Cholesterol reductase was discovered in certain green plant parts. The enzyme is known to be present in
several bacteria that commonly inhabit the digestive tract of animals. Eubacteria species A.T.C.C. 21408 is one
such cholesterol reductase-containing bacterium. It is concentrated from a homogenate, preferably of leaves of
plants or from bacteria or other organisms to provide a cell-free, cholesterol reductase-enriched preparation
that can be used to decrease cholesterol content of food substances.
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METHOD OF CONVERTING CHOLESTEROL IN 
FOOD TO COPROSTANOL 
BACKGROUND OF THE INVENTION 
It is generally recognized that high blood cholesterol 
concentrations provide a signi?cant risk factor in heart 
disease. It is also generally recognized that eating foods 
high in saturated fats, like many red meats may contrib 
ute signi?cantly to increased blood cholesterol concen 
trations in humans. correspondingly, the increased 
blood cholesterol concentration in humans seems to 
have a direct positive correlation with coronary heart 
disease. Accordingly, there is a continuing and real 
interest in decreasing the intake of food substances that 
have high cholesterol content. Thus, there has been in 
the past years a signi?cant health trend away from red 
meat, milk products, and eggs. 
Accordingly, there is a continuing and real need to 
develop techniques for decreasing cholesterol concen 
trations in food substances, and particularly in slaughter 
animals that are to be used in preparation of table meats 
and in eggs. 
Cholesterol reductase is a known enzyme that cata 
lyzes the chemical reduction of cholesterol to coprosta 
nol. However, heretofore, it has been believed and 
found that cholesterol reductase is present only in cer 
tain bacteria. It has now been discovered that choles 
terol reductase is present in certain green plant parts, 
particularly the leaves of green leafy plants, such as 
soybeans, corn, and cucumbers. It is believed that the 
applicants are the ?rst ever to discover and take advan 
tage of the existence of cholesterol reductase in green 
plant parts. 
It is a primary objective of the present invention to 
provide a method of concentrating cholesterol reduc 
tase from green plant parts. 
Another primary objective of the present invention is 
to use cholesterol reductase derived from green plant 
parts or from bacterial sources such as Eubacteria spe 
cies A.T.C.C. 21408 to treat food substances that con 
tain cholesterol in order to decrease the concentration 
of cholesterol therein. 
It is a further objective of the present invention to 
provide a means of decreasing cholesterol concentra 
tion in cell membranes of the muscle of meat source 
animals. . 
An even further objective of the present invention is 
to decrease the health risk of people that use red meat 
and other animal products used as food, such as swine, 
poultry, ?sh, eggs, and milk products, by decreasing the 
cholesterol concentration of the food products. 
The method and means of accomplishing each of the 
above objectives as well as others will become apparent 
from the detailed description of the invention that fol 
lows hereinafter. 
SUMMARY OF THE INVENTION 
This invention is premised on the discovery that cho 
lesterol reductase can be extracted and concentrated 
from green plant parts, particularly of cucumbers, soy 
bean, and corn. The process involves homogenizing the 
green plant parts, separating the ?brous materials from 
the crude homogenate, and concentrating the homoge 
nate to provide a cell-free, cytosolic, cholesterol reduc 
tase-enriched preparation, or ultimately a cholesterol 
reductase puri?ed to homogeneity. A cholesterol re 
ductase~enriched extract or the puri?ed enzyme may 
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also be prepared from Eubacteria species A.T.C.C. 
21408 or other cholesterol reductase-containing bac 
teria. The enzyme preparation may be used to treat food 
products to convert cholesterol to coprostanol, thus 
decreasing the amount of cholesterol in food. In a pre 
ferred embodiment of the invention, the enzyme is used 
to decrease cholesterol concentrations in meat animals, 
including poultry, by injecting into the animals just 
before slaughter. 
DETAILED DESCRIPTION OF THE 
INVENTION 
In accordance with the process of this invention, 
cholesterol reductase is extracted from green plant parts 
by homogenizing the green plant parts in an isotonic 
aqueous-based buffered salt solution that generally has a 
pH in the range from about 6.0 to about 7.5. 
The discovery of cholesterol reductase as being pres‘ 
ent in certain green plant parts, particularly the leaves, 
is believed new. It is believed to be present in all green 
plant parts, but it- is most easily homogenized, separated, 
and concentrated from the leaves that provide the least 
cell debris. Particularly preferred plants are members of 
the grass and legume families. Plants that have been 
tested successfully from the standpoint of successful 
isolation of cholesterol reductase are not limited to but 
do include, cucumbers, soybeans, corn, peas, garden 
green beans, etc. To date, those that seem to have the 
greatest concentration and that have been used most 
successfully, and therefore are preferred include cu 
cumbers, soybeans, and corn. 
In the ?rst step of the concentration process of this 
invention, a homogenate is prepared. The amount of 
homogenization media is generally from about 2 mL/ gr 
to about 20 mL/gr of green plant part, and generally 
preferred is from about 5 mL/ gr to about 10 mL/ gr of 
leaf parts. Concentration does not, however, appear 
critical. The homogenization media is an aqueous 
based, isotonically buffered salt solution that has a pH 
from about 6.0 to about 7.5. The preferred pH is from 
about 6.5 to about 7.0. 
Various known isotonic aqueous-based, buffered salt 
solutions used in plant part homogenization may be 
successfully employed. For example, the buffered solu 
tion may be a phosphate buffer solution or a Tris-buff 
ered solution. Generally speaking, any of those aque 
ous-based isotonic solutions commercially available that 
have a buffering capacity within the pH range speci?ed 
may be employed. However, satisfactory results have 
been obtained with phosphate buffered solutions, which 
are therefore preferred. 
The usual components in a buffered phosphate solu— 
tion may also contain compounds known to chelate 
divalent cations that may have a potential for denatur 
ing the enzyme during puri?cation. It has been found 
preferable to add a chelating agent for divalent cations 
to the buffered salt solution. Suitable ones include ethyl 
enediaminetetraacetic acid (EDTA). It is not believed 
that it is absolutely necessary to have a chelating agent, 
such as ethylenediaminetetraacetic acid in the homoge 
nization buffered solution, but there may be times when 
it is useful. Also, reducing agents, such as sodium meta 
bisul?te, ascorbate, and dithiothreitol, are added rou 
tinely to the homogenization buffer as insurance against 
enzyme inactivation during subsequent puri?cation 
steps. Reducing agents are, however, not essential but 
only preferred. Generally speaking, where chelating 
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agents for divalent cations such as EDTA are added, 
the amount present should be a small but effective 
amount of the buffer solution, generally from 0.05 mM 
to 0.50 mM, and preferably from 0.05 mM to 0.1 mM. 
Where reducing agents such as metabisul?te are added, 
the amount should be from 5 mM to 15 mM. 
The plant parts are simply added to the homogeniza 
tion media described above at the concentrations earlier 
described, and thereafter homogenized in a conven 
tional homogenizer, for example a top-drive Virtis ho 
mogenizer. The homogenization does not appear to be 
critical time-wise, and satisfactory results can be ob 
tained by using, for example, four bursts of homogeniza 
tion of approximately 15 seconds each. Thereafter, the 
homogenate is ready for enzyme puri?cation and con 
centration. 
The homogenate is thereafter ?ltered, for example, 
gravity ?ltered and finally squeezed through a cheese 
cloth. The residue is then discarded, and the ?ltrate 
centrifuged. centrifuging‘ can be, for example, at 
27,000Xg for 20 minutes. However, centrifugation is 
not time-dependent and can generally range from 10 
minutes to about 30 minutes. After this centrifuge pro 
cess, the supernatant of the centrifugation is itself cen 
trifuged, for example at l40,000>< g for 1 hour. The 
resulting supernatant (cytosol) can then be dialyzed 
against a solution of 5 mM phosphate buffer, at a pH of 
about 6.5. The buffer may also contain a reducing agent 
such as 0.5 mM of dithiothreitol and may also contain 
10% glycerol for the purpose of stabilization of choles 
terol reductase.~ The dialyzed supernatant contains the 
concentrated cholesterol reductase-enriched prepara 
tion. 
Thus, it can be seen that ?rst homogenization occurs, 
followed by separating of the ?brous materials from the 
crude homogenate, thereafter concentrating the ho 
mogenate to provide a cell-free, cytosolic, cholesterol 
reductase-enriched preparation. 
Cholesterol reductase-containing bacteria can be ho 
mogenized by sani?cation by use of a French press or 
by mechanical shear. The homogenate can then be 
treated as described for the plant homogenate to con 
centrate the cholesterol reductase enzyme. 
For commercial production of cholesterol reductase 
the gene or genes for cholesterol reductase may be 
transferred into another bacterial species such as E. coli. 
The process would be similar to that now in use for 
making human insulin, bovine growth hormone, and 
porcine growth hormone. 
It is very conceivable that the concentrate can be 
further treated to obtain substantially 100% pure cho 
lesterol reductase; however, it has been found that this 
may not be needed, and that the cell-free, cytosolic, 
cholesterol reductase-enriched preparation itself may 
be used for the subsequently described methods of 
chemically reducing cholesterol to coprostanol. 
Coprostanol is normally produced in the intestine of 
animals. It represents cholesterol that has been hydro 
genated. Coprostanol is poorly absorbed by humans, 
and the reduction of cholesterol to coprostanol is en 
hanced by the enzymatic activity of cholesterol reduc 
tase. 
In accordance with the method of decreasing choles 
terol concentration in food substances, the method of 
this invention involves treating the food substance with 
a green plant derived cell-free, cytosolic, cholesterol 
reductase enriched preparation or a cholesterol reduc~ 
tase from a bacterial source. This treatment simply en 
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zymatically enhances the chemical reduction of choles 
terol to coprostanol. However, because coprostanol is 
not absorbed, it does not increase the cholesterol con 
centration in the person consuming the food substance. 
Thus, the green plant derived cell-free, cytosolic cho 
lesterol reductase-enriched preparation or the bacterial 
cholesterol reductase can be successfully used to de 
crease heart disease risk. It simply involves cellular 
release of the cholesterol reductase followed by partial 
puri?cation, and thereafter treating the food substance 
with the cholesterol reductase-enriched preparation. 
In a preferred embodiment of the present invention, it 
has been discovered that decreasing cholesterol concen 
tration in food animals to be used to provide meat can 
be effectively accomplished with use of cholesterol 
reductase. In this operation, the animal is administered 
intravenously a safe and effective cholesterol reducing 
amount of the cell-free, cytosolic, cholesterol reduc 
tase-enriched preparation. The animal is administered 
this prior to slaughter, preferably within an hour of 
slaughter, commonly within 30 minutes of slaughter, 
and in every instance at least 15 minutes before slaugh 
ter. When this is done, the cholesterol reductase signi? 
cantly decreases the amount of cholesterol present in 
the cell membranes of the muscle; In most instances, the 
amount of reduction is at least 50% and in all instances 
seems to be at least at the 25% level. All meat-produc 
ing animals, such as cattle, sheep, swine, and poultry, 
can be treated by this procedure because they contain 
cholesterol. It would also be possible to treat ?sh in a 
similar manner. 
For treatment of milk, the enzyme can be added to 
homogenized milk. Alternatively, milk may be passed 
through an enzyme-supporting inert material. For eggs, 
the enzyme can be injected into the yolk of the whole 
egg or added to broken egg mixtures of yolk and white. 
For meats, the enzyme can be added to ground prepara 
tions of meats of the several species of animals. 
The amount of the cholesterol reductase preparation 
that may be administered to the animal will vary, de 
pending upon body weight; its effect is, of course, time 
dependent between the time of administration and 
slaughter. However, generally speaking, the amount 
will be from about 0.01 mg protein/kg of animal body 
weight to about 2.50 mg protein/kg of animal body 
weight. Most preferably the amount will be from about 
0.05‘ mg/kg of animal body weight to about 0.5 mg/kg 
of animal body weight. 
The following examples are offered to further. illus 
trate but not limit the process of the present invention. 
EXAMPLE 1 
Cucumber plants were grown under controlled con 
ditions in a greenhouse. Washed cucumber leaves (3-6 
weeks old) were homogenized in sodium/potassium 
phosphate buffer (100 mM, pH 6.5) containing sucrose 
(150 mM), sodium metabisul?te (10 mM), ascorbic acid 
(10 mM), dithiothreitol (5 mM), and ethylenediamine 
tetraacetic acid (0.1 mM). Polyvinylpolypyrrolidone 
and XAD-4 were added to the homogenization me 
dium. The crude homogenate was ?ltered through sev 
eral layers of cheesecloth, and the ?ltrate was centri 
fuged at 27,000Xg for 20 min. The resulting superna 
tant was centrifuged at 140,000X g for l h, and the ?nal 
supernatant was employed as the cholesterol reductase 
source after dialysis at 4° C. against 10 mM sodium/ 
potassium phosphate buffer (pH 6.5) containing 20 mM 
- 
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2-[N-morpholino]ethanesulfonic acid, 0.5 mM dithio 
threitol, and 10%(v/v) glycerol. 
The enzyme solutions were assayed for cholesterol 
reductase activity by adding radiolabeled cholesterol 
and a reducing agent (1.0 mM NADH or NADPH). 
After incubating for 1 h at 37° C., the reaction mixture 
was cooled to about 4° C. and extracted three times 
with diethylether. The ether extract, after the addition 
of unlabelled cholesterol and coprostanol as chromato 
graphic standards, was concentrated under vacuum and 
chromatographed on a silica gel H thin-layer plate (0.75 
mm thickness) in a solvent system of benzene:ethylace 
tate (5:1). The developed chromatogram was sprayed 
with a 0.2% ethanolic solution of 2,7-dichlorofluore 
scein and visualized under ultraviolet light. The appro 
priate bands were scraped directly into a scintillation 
vial for determination of radioactivity. ’ 
To determine the cellular compartment where cho 
lesterol reductase is located in cucumber leaves, the 
27,000>< g supernatant, the 27,000>< g pellet, the 
140,000>< g supernatant (cytosol), and the 140,000Xg 
pellet were assayed for activity. The 27,000><g pellet 
had virtually no activity, whereas the 140,000Xg pellet 
had 10 to 15% as much activity as the l40,000>< g super 
natant. Reductase activity in the 140,000Xg pellet was 
decreased even further to about 5% when the pellet was 
suspended in buffer and recentrifuged. Thus, most of 
the original cholesterol reductase activity was observed 
in the l40,000>< g supernatant. From these observations, 
it was concluded that the cholesterol reductase activity 
is located in the cytosol of cucumber leaves. 
To obtain preliminary information on the optimal pH 
of cholesterol reductase, the l40,000>< g supernatant 
was dialyzed and assayed at pH 5.5, 6.0, 6.5, 7.0, and 8.0. 
The optimal pH was observed to be pH 6.5. In addition, 
two reducing agents, NADH and NADPH, were as 
sayed for their efficacy in the cholesterol reductase 
reaction. It was found that NADPH is the preferred 
reducing agent by a factor of 3 to 4 over NADH at 1.0 
mM concentration. 
Once preliminary information was determined on the 
optimal pH and the preferred reducing agent, several 
different steps for enzyme puri?cation were tested. One 
method used was ammonium sulfate precipitation be 
cause this would not only decrease the volume of ho 
mogenate but also would result in some enzyme puri? 
cation. Saturating the enzyme preparation with up to 
100% ammonium sulfate precipitated only 10 to 15% of 
the original activity. The supernatant, however, con 
tained 150 to 200% of the original activity. This result 
indicates that cholesterol reductase was not highly hy 
drophobic and that some inhibiting and/or competing 
proteins or other factors are removed by ammonium 
sulfate treatment. 
This treatment with polyvinylpolypyrrolidone and 
XAD-4 resin is preferred to remove phenolic com 
pounds that inhibit several plant enzymes. The two 
treatment compounds adsorb phenolics and thereby 
remove them from the test solutions. For further details 
with regard to techniques that may be employed in 
puri?cation of plant lipid-metabolizing enzymes, see 
Loomis et al., “Adsorbent Polystyrene as an Aid in 
Plant Enzyme Isolation,” Phytochemistry, Vol. 18, pp. 
1049-1054 (1979); Loomis, W. D., “Overcoming Prob 
lems of Phenolics and Quinones in the Isolation of Plant 
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Enzymes and Organelles,” Methods of Enzymology, Vol. 
31, pp. 528-545 (1974); and Kohmoto et al., “A Simple 
Method For Preparing Physiologically Active Mito 
chondria From Plant Leaves Rich In Oils And Pheno 
lics,” Plant Cell Reports, 5:54-56 (1986). 
EXAMPLE II 
Preliminary experiments have used cholesterol oxi 
dase, which is commercially available, as a model en 
zyme to determine whether cholesterol in milk is acces 
sible to enzymatic attack. Data from these experiments 
indicate that 80% to 90% of the cholesterol in homoge 
nized, pasteurized, whole milk would be accessible to 
reduction to coprostanol by cholesterol reductase. Re 
sults with raw, whole milk have been more variable but 
suggest that 60% to 80% of its cholesterol would be 
accessible to cholesterol reductase. 
EXAMPLE III 
When beef cattle and other meat-producing animals 
are treated with the cholesterol reductase concentrate, 
prepared in the manner of Example I, just prior to 
slaughter by injection at a level of approximately 0.05 
mg/ kg of body weight, cholesterol reductase will circu 
late through the extracellular space of the animal body 
(minus the digestive system) and interact with extracel 
lular and membranous cholesterol and catalyze its con 
version to coprostanol. Because humans absorb copro 
stanol very poorly, this treatment of meat animals will 
decrease the concentration of cholesterol in meat and 
thus result in an effective method for production of low 
cholesterol meats. 
When in Example I, the cucumbers used therein are 
replaced with corn, peas, soybeans, or other choles 
terol-containing reductase plants, similar results are 
achieved. Likewise in Example III, if the meat source is 
other than beef such as swine, poultry, or even ?sh, 
similar reductions in cholesterol level will be noticed. 
It therefore can be seen that the invention accom 
plishes at least all of its stated objectives. 
What is claimed is: 
1. A method of decreasing cholesterol concentration 
in animal origin foods, consisting essentially of: treating 
cholesterol~containing, animal origin foods 
with a reductase organism 
cell-free, cholesterol reductase-enriched preparation 
in an amount effective to reduce cholesterol to 
coprostanol and to substantially lower the choles 
terol concentration of the foods. 
2. The method of claim 1 wherein said food is a meat. 
3. The method of claim 2 wherein a reducing agent is 
added to said cholesterol reductase-enriched prepara 
tion. 
4. The method of claim 1 wherein said food is milk. 
5. The method of claim 4 wherein a reducing agent is 
added to said cholesterol reductase-enriched prepara 
tion. 
6. The method of claim 1 wherein said food is an egg. 
7. The method of claim 6 wherein a reducing agent is 
added to said cholesterol reductase-enriched prepara 
tion. 
8. The method of claim 1 wherein a reducing agent is 
added to said cholesterol reductase-enriched prepara 
tion. 
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